Keywords:
Chromosome Aberrations; Chromosomes; Ependymoma/genetics; Microarray Analysis; Progression-Free Survival; ependymoma;
subgrouping
Abstract:
Within PF-EPN-A, 1q gain is a marker of poor prognosis, however, it is unclear if within PF-EPN-A additional cytogenetic events exist which can refine risk stratification.